| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.080 | 9.397 | 9.465 | 9.692 | 12.068 | 23.161 | 55.666 | 56.134 | 56.660 | 55.420 |
| Total Income - EUR | 12.080 | 9.399 | 9.465 | 9.692 | 12.068 | 23.163 | 55.676 | 56.235 | 56.670 | 55.445 |
| Total Expenses - EUR | 11.238 | 12.064 | 8.786 | 8.817 | 9.856 | 9.329 | 15.143 | 14.935 | 25.669 | 29.939 |
| Gross Profit/Loss - EUR | 842 | -2.666 | 679 | 876 | 2.212 | 13.834 | 40.533 | 41.300 | 31.001 | 25.505 |
| Net Profit/Loss - EUR | 480 | -2.854 | 585 | 779 | 2.092 | 13.602 | 39.976 | 40.749 | 30.446 | 25.017 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Biosvet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.836 | 6.479 | 6.088 | 5.700 | 5.318 | 4.951 | 4.661 | 5.362 | 6.079 | 6.577 |
| Current Assets | 11.940 | 9.317 | 9.883 | 11.117 | 12.566 | 26.682 | 41.280 | 39.002 | 26.135 | 24.431 |
| Inventories | 0 | 0 | 0 | 0 | 840 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 99 | 508 | 651 | 4.243 | 3.602 | 6.782 | 14.055 | 394 | 1.219 |
| Cash | 11.940 | 9.218 | 9.375 | 10.466 | 7.482 | 23.079 | 34.498 | 24.947 | 25.741 | 23.212 |
| Shareholders Funds | 17.191 | 14.161 | 14.506 | 15.019 | 16.820 | 30.104 | 43.877 | 40.789 | 30.588 | 29.119 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.585 | 1.635 | 1.465 | 1.798 | 1.064 | 1.529 | 2.064 | 3.575 | 1.625 | 1.888 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8520 - 8520" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Biosvet Srl